Novel Neoantigen Screening Tool: QuickSwitch™ Custom Tetramer Kits
A rapid high throughput and user friendly system for creating new tetramer specificities. Tetramers resulting from peptide exchange with selected peptides can be used for immune monitoring.
Useful for research involving cancer neoantigens, infectious agents and many other research areas.
Learn more about our QuickSwitch™ products.
MBL International is here to work with you and advance your unique research needs using custom services. We can help with Immuno-monitoring services using MHC Tetramers and Cytokines. Contact us today for more information.
MBL International will be exhibiting at the following shows:
Aug 25 – 27: Cell Symposium: Engineering Organs and Organoids in San Diego, CA
Nov 6 – 10: SITC 2019 in National Harbor, MD
Jan. 23, 2018 – Sunnyvale, CA – JSR Life Sciences, the life sciences-focused business unit of JSR Corporation, announced today that it has appointed Dr. Nalini Murdter as the President and Chief Executive Officer of MBL International (MBLI) effective immediately.
May 22nd, 2017: MEDICAL & BIOLOGICAL LABORATORIES Co., Ltd. (MBL) announced that it has entered into a collaboration agreement with the p53 Laboratory, Agency for Science, Technology and Research (A*STAR) in Singapore to establish the novel screening technology which accelerates the drug discovery targeting Protein-Protein Interactions (PPIs).
Thu, 13 Jun 2019 17:00:00 GMT
Wed, 24 Apr 2019 17:00:00 GMT
Fri, 29 Mar 2019 17:00:00 GMT